Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.2.9289.4699
Address
Level 3 120 Sussex Street Sydney, New South Wales (NSW) 2000
Description
PharmX Technologies Ltd. engages in the research and development of software solutions. It operates through the Health Services and eCommerce segment. The Health Services segment provides dispense and point of sale software applications, along with hardware and support services to Australian pharmacies. The eCommerce segment offers individuals and businesses the opportunity to pay their rent, utilities, local government fees, and commercial obligations via electronic methodologies. The company was founded in 1950 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.06
Trade Value (12mth)
AU$2,990.00
1 week
-9.09%
1 month
42.86%
YTD
38.89%
1 year
34.17%
All time high
0.63
EPS 3 yr Growth
-460.000%
EBITDA Margin
23.20%
Operating Cashflow
$11m
Free Cash Flow Return
48.20%
ROIC
-3.90%
Interest Coverage
25.90
Quick Ratio
1.80
Shares on Issue (Fully Dilluted)
598m
HALO Sector
Technology
Next Company Report Date
21-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
24 July 24 |
Notice of Results Announcement 30 June 2024
×
Notice of Results Announcement 30 June 2024 |
18 July 24 |
ATO confirms tax implications of return of share capital
×
ATO confirms tax implications of return of share capital |
30 May 24 |
Update on Fred Appeals in Legal Proceedings
×
Update on Fred Appeals in Legal Proceedings |
01 March 24 |
Notification regarding unquoted securities - PHX
×
Notification regarding unquoted securities - PHX |
23 February 24 |
Appendix 4D and HY Report for 31 Dec 2023
×
Appendix 4D and HY Report for 31 Dec 2023 |
23 February 24 |
Results for the HY ended 31 Dec 2023
×
Results for the HY ended 31 Dec 2023 |
23 February 24 |
Investor Presentation
×
Investor Presentation |
22 February 24 |
Appointment of Interim CFO and change of Company Secretary
×
Appointment of Interim CFO and change of Company Secretary |
16 February 24 |
Change of Director's Interest Notice - N England
×
Change of Director's Interest Notice - N England |
14 February 24 |
Notice of Results Announcement
×
Notice of Results Announcement |
12 February 24 |
Response to ASX Price Query
×
Response to ASX Price Query |
05 December 23 |
Capital Return Confirmation
×
Capital Return Confirmation |
22 November 23 |
Return of Capital - PHX
×
Return of Capital - PHX |
21 November 23 |
Chair's Address to Shareholders
×
Chair's Address to Shareholders |
21 November 23 |
Results of Meeting
×
Results of Meeting |
15 November 23 |
Appointment of Chief Executive Officer
×
Appointment of Chief Executive Officer |
20 October 23 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
17 October 23 |
Notification of cessation of securities - PHX
×
Notification of cessation of securities - PHX |
16 October 23 |
Application for quotation of securities - PHX
×
Application for quotation of securities - PHX |
04 October 23 |
Change of Company Name
×
Change of Company Name |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.